Oxford Biomedica and bio Research announced a R&D collaboration that aims to use cloud and machine learning to improve the purity and efficiency of next - gen cell- and gene - delivery technologies . Combining the companies ’ technologies is aiming to help develop Biomedica - which is also working with Synthace to further hone manufacturing process design , simulation and execution – both to develop new treatments and increase the cost effectiveness of existing treatments .
Oxford Biomedica and Microsoft Research announced a R&D collaboration that aims to use cloud and machine learning to improve the purity and yield of next-gen cell- and gene-delivery technology. Combining the companies’ technologies is expected to help Oxford Biomedica - which is also working with Synthace to further hone manufacturing process design, simulation and execution – both to develop new treatments and increase the cost effectiveness of existing ones.